Tag Archives: drug

Transparency by drug companies, scrutiny by journalists, vital in vaccine news

Pfizer’s chairman and CEO proclaimed in a Pfizer company news release: “Today is a great day for science and humanity.” In that PR news release – but only in that format – Pfizer announced early results of “a vaccine efficacy rate above 90%, at 7 days after the second dose.” That’s about all we know… Read More »

It has come to this: ignore vaccines-in-animals drug industry PR & news

A long-haired male golden hamster (via Wikipedia & Creative Commons) Earlier this week, a powerful opinion piece, “It Has Come To This:  Ignore the CDC,”  co-authored by former National Institutes of Health director Harold Varmus,  was published in the New York Times. That’s on the science side. On the PR and journalism side, it has… Read More »

John Ivison: The math of saving lives — Canada’s drug battle leaves patients caught in the middle

Article content continued We feel that everyone is blaming someone else and patients are caught in the middle Vertex has done spectacularly well from Trikafta this year, reporting sales of US$ 918 million in second quarter of this year, from zero last year. That helped the company’s net income to soar 213 per cent year… Read More »

Drug being tested for at-home treatment in hopes of slowing virus

Researchers at Beth Israel Deaconess Medical Center are testing a new approach to fighting COVID-19, using a repurposed antiviral AIDS drug for at-home treatment during the first days of symptoms in hopes of slowing the virus early and heading off hospitalization, intensive care, and death. The nationwide clinical trial is being led by Nathan Shapiro,… Read More »

Accutane Acne Drug Widely ‘Overused’ Says UK Dermatologist

By Dr. Mercola Up to 50 million Americans struggle with acne, making it the most common skin disorder in the United States.1 When it strikes during the teen years, it can lead to feelings of self-consciousness, embarrassment and depression. Many severe acne sufferers struggle with low self-confidence, feelings of alienation and social withdrawal as a… Read More »

FiercePharmaAsia—COVID-19 drug manufacturing; Roche’s China slowdown; Astellas’ Iota buy

Takeda and CSL Behring are scaling up manufacturing of their coronavirus hyperimmune drug, but its reliance on blood donations could be a bottleneck. Eli Lilly has signed on Fujifilm to help make its COVID-19 antibody therapy as part of a Bill & Melinda Gates Foundation initiative to bring drugs for low- and middle-income countries. Roche blames… Read More »